Provided by Tiger Trade Technology Pte. Ltd.

AQR Capital Holdings

2,718.82
+9.830.36%
Number of Gainers:56
Number of Losers:41
Number of Flat:1
PE:- -
High:2,727.96
Open:2,708.94
Low:2,708.43
Close:2,708.99
Volume:1.01B
Turnover:207.49B
Market Cap:49.73T
Float Cap:46.27T

Loading ...

Google Shows It's not Out of the AI Race Just Yet

Dow Jones
·
Oct 01

NextEra Energy Unit Selected to Work on $22B Texas Energy Infrastructure Campus

Dow Jones
·
Oct 01

Overnight News for October 1: Trump Pressures Powell to Resign Again, Paramount Issues $30 Billion in Bonds, US August Inflation Below Expectations, Goldman Sachs Delays Rate Hike Forecast to December

Deep News
·
Oct 01

Eli Lilly Says Foundayo Drug Helped Patients Lose Weight in Phase 3 Trial

Dow Jones
·
Oct 01

Tech CEOs Privately Questioned Amodei for Sounding AI Alarm Bells

Dow Jones
·
Oct 01

U.S., South Korea Announce $22.30 Bln Investment in Project Star Energy Campus in Texas

Reuters
·
Oct 01

NextEra Energy selected to participate in development of $22B energy campus

TIPRANKS
·
Oct 01

Newmont (NEM) Could Be 31% Undervalued On Record Free Cash Flow And Gold Price Swings

Simply Wall St.
·
Oct 01

US Defense Secretary: Musk, Palmer Luckey, and Newt Gingrich to Help Pentagon Advance War Plans

Deep News
·
Oct 01

NextEra, Related Companies to Develop USD 22.3 Billion Project Star Natural Gas Power Campus in Texas

Reuters
·
Oct 01

Nextera Energy, - Project Star to Create 6.47 Gw Natural Gas Generation Supporting 5 Gw Digital Campus

THOMSON REUTERS
·
Oct 01

Nextera Energy, - Project Star Initial Generation Expected Online as Early as 2029

THOMSON REUTERS
·
Oct 01

Micron 4Q Profit, Revenue Surge as Memory Crunch Looks to Last Through 2028

Dow Jones
·
Oct 01

Analysts Are Bullish on These NA Stocks: Moleculin Biotech (MBRX), Alphabet Class A (GOOGL)

TIPRANKS
·
Oct 01

Eli Lilly’s Foundayo shows cardiovascular safety in type 2 diabetes study

TIPRANKS
·
Oct 01

Lilly's Oral Glp-1, Foundayo (Orforglipron), Demonstrated Cardiovascular Safety Alongside Sustained A1c Reduction and Weight Loss in Its Largest and Longest Type 2 Diabetes Study

THOMSON REUTERS
·
Oct 01

Eli Lilly - Achieve-4: Foundayo Shows 16% Lower Mace-4 and 23% Lower Mace-3 Risk vs Insulin Glargine

THOMSON REUTERS
·
Oct 01

Eli Lilly - Foundayo Shows Smaller Egrf Reduction and Greater Albuminuria Reduction vs Insulin Glargine

THOMSON REUTERS
·
Oct 01

Costco EVP Claudine Adamo Sells 2,200 Shares Worth $2,014,?46**

Reuters
·
Oct 01

Micron Q4 Revenue Nearly Quadruples, Q1 Guidance Beats Expectations, but Gross Margin Outlook Disappoints, Stock Rises Then Falls After Hours

Deep News
·
Oct 01